Mutual of America Capital Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.27M | Buy |
38,357
+1,926
| +5% | +$265K | 0.06% | 416 |
|
|
2025
Q1 | $6.57M | Sell |
36,431
-87
| -0.2% | -$15.7K | 0.08% | 296 |
|
|
2024
Q4 | $5.72M | Sell |
36,518
-48
| -0.1% | -$7.52K | 0.06% | 377 |
|
|
2024
Q3 | $6.66M | Sell |
36,566
-758
| -2% | -$138K | 0.07% | 327 |
|
|
2024
Q2 | $6.85M | Buy |
37,324
+3,135
| +9% | +$576K | 0.07% | 295 |
|
|
2024
Q1 | $6.08M | Sell |
34,189
-2,199
| -6% | -$391K | 0.07% | 364 |
|
|
2023
Q4 | $4.51M | Sell |
36,388
-1,151
| -3% | -$143K | 0.05% | 510 |
|
|
2023
Q3 | $4.35M | Sell |
37,539
-962
| -2% | -$112K | 0.05% | 484 |
|
|
2023
Q2 | $4.52M | Buy |
38,501
+12,950
| +51% | +$1.52M | 0.05% | 516 |
|
|
2023
Q1 | $2.05M | Sell |
25,551
-1,177
| -4% | -$94.2K | 0.02% | 889 |
|
|
2022
Q4 | $2.12M | Buy |
26,728
+365
| +1% | +$28.9K | 0.03% | 882 |
|
|
2022
Q3 | $1.84M | Sell |
26,363
-2,401
| -8% | -$167K | 0.02% | 881 |
|
|
2022
Q2 | $1.89M | Sell |
28,764
-216
| -0.7% | -$14.2K | 0.02% | 899 |
|
|
2022
Q1 | $1.93M | Sell |
28,980
-1,257
| -4% | -$83.6K | 0.02% | 969 |
|
|
2021
Q4 | $2.12M | Sell |
30,237
-281
| -0.9% | -$19.7K | 0.02% | 960 |
|
|
2021
Q3 | $1.59M | Sell |
30,518
-438
| -1% | -$22.9K | 0.02% | 1008 |
|
|
2021
Q2 | $2.11M | Sell |
30,956
-1,333
| -4% | -$90.6K | 0.02% | 960 |
|
|
2021
Q1 | $2.49M | Sell |
32,289
-1,786
| -5% | -$138K | 0.03% | 870 |
|
|
2020
Q4 | $2.04M | Buy |
34,075
+5,006
| +17% | +$300K | 0.02% | 889 |
|
|
2020
Q3 | $1.25M | Buy |
29,069
+2,638
| +10% | +$114K | 0.02% | 997 |
|
|
2020
Q2 | $1.1M | Sell |
26,431
-1,788
| -6% | -$74.1K | 0.02% | 1027 |
|
|
2020
Q1 | $1.22M | Sell |
28,219
-1,241
| -4% | -$53.7K | 0.02% | 910 |
|
|
2019
Q4 | $1.63M | Buy |
+29,460
| New | +$1.63M | 0.02% | 994 |
|